切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2017, Vol. 06 ›› Issue (03) : 238 -242. doi: 10.3877/cma.j.issn.2095-3224.2017.03.014

所属专题: 文献

综述

大肠癌肝转移治疗进展
李奕1, 邰升1,()   
  1. 1. 150086 哈尔滨医科大学附属第二医院胆胰外科
  • 收稿日期:2017-01-22 出版日期:2017-06-25
  • 通信作者: 邰升

Progression of treatments for colorectal liver metastasis

Yi Li1, Sheng Tai1,()   

  1. 1. Department of Biliary-Pancreatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China
  • Received:2017-01-22 Published:2017-06-25
  • Corresponding author: Sheng Tai
  • About author:
    Corresponding author: Tai Sheng, Email:
引用本文:

李奕, 邰升. 大肠癌肝转移治疗进展[J]. 中华结直肠疾病电子杂志, 2017, 06(03): 238-242.

Yi Li, Sheng Tai. Progression of treatments for colorectal liver metastasis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(03): 238-242.

肝脏是大肠癌远处转移最为常见的器官之一,正确有效的肝转移治疗不但延缓疾病进程,延长患者寿命,同时也能为患者的预后质量提供良好保障。目前外科手术切除治疗仍是大肠癌肝转移的首选,随着相关技术的不断发展以及人们对大肠癌肝转移研究的不断深入,放射疗法、冷冻疗法、射频消融术等新型治疗手段也在不断得以实践,多学科综合治疗将为大肠癌肝转移的临床治疗提供新的研究方向。

Liver is one of the most common organs for colorectal cancer distant metastasis, a correct and effective treatment applied in the regulation of liver metastasis could not only delay of disease progression but also extend the survival time, at the same time providing a better guarantee for the prognosis of patients with quality. Up to now, surgical resection still counts for the first selection for colorectal liver metastasis. With the continuous development of related technologies and the deep insights into this malignant biological behavior, new treatments are able to be practiced constantly, including radiotherapy, cryotherapy, radiofrequency and other approaches. Thus, multidisciplinary synthetic therapy will designate research direction for the treatment of colorectal liver metastasis.

[1]
中华医学会外科学分会胃肠外科学组. 结直肠癌肝转移诊断和综合治疗指南(2016版) [J]. 中华消化外科杂志, 2016, 15(8):755-767.
[2]
Esfahani S, Heidari P, Sheth R, et al. Non-invasive imaging of C-MET receptor for delineation of liver metastasis of colorectal cancer [J]. Journal of Nuclear Medicine, 2013, 54(2):300-305.
[3]
中国抗癌协会大肠癌专业委员会专家组. 结直肠癌肝转移转化治疗中靶向药物合理应用的专家指导意见 [J]. 中华胃肠外科杂志, 2013, 16(10):1000-1004.
[4]
林俊忠, 潘志忠. 结直肠癌肝转移外科治疗的争议 [J]. 中华胃肠外科杂志, 2013, 16(8):714-717.
[5]
邢宝才. 结直肠癌肝转移的规范化治疗 [J]. 中华消化外科杂志, 2013, 12(6):413-416.
[6]
Ter Voert EG, Heijmen L, de Wilt JH, et al. Reproducibility and biological basis of in vivo T(2)* magnetic resonance imaging of liver metastasis of colorectal cancer [J]. Magnetic Resonance in Medicine, 2013, 70(4):1145–1152.
[7]
孙谊, 闫晓峦, 王崑, 等. 结直肠癌多发性肝转移手术切除的疗效 [J]. 中华肝胆外科杂志, 2014, 20(3):195-200.
[8]
刘德军, 陈炜, 张斌, 等. 结直肠癌同时性肝转移手术时机的选择 [J]. 中华消化外科杂志, 2012, 11(3):294-295.
[9]
胡俊杰, 周志祥, 梁建伟, 等. 结直肠癌同时性肝转移同期手术切除疗效分析 [J]. 中华肿瘤杂志, 2013, 35(1):63-66.
[10]
盛勤松, 林才照, 严盛, 等. 手助腹腔镜结直肠癌肝转移一期同步切除术六例分析 [J]. 中华普通外科杂志, 2012, 27(12):982-984.
[11]
周进学, 王凯, 李庆军, 等. 腹腔镜结直肠癌肝转移一期切除术的临床疗效 [J]. 中华消化外科杂志, 2016, 15(2):135-139.
[12]
Chen Dong-liang, Wang Zhi-qiang, Zeng Zhao-lei, et al. Identification of MicroRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression [J]. Hepatology, 2014, 60(2):598–609.
[13]
Yuge R, Kitadai Y, Shinagawa K, et al. mTOR and PDGF pathway blockade inhibits liver metastasis of colorectal cancer by modulating the tumor microenvironment [J]. American Journal of Pathology, 2015, 185(2):399-408.
[14]
朱德祥, 任黎, 许剑民. 伴有同时性不可切除肝转移的结直肠癌患者治疗的思考 [J]. 中华胃肠外科杂志, 2013, 16(8):718-720.
[15]
Weidle UH, Birzele F, Krüger A. Molecular targets and pathways involved in liver metastasis of colorectal cancer [J]. Clinical & Experimental Metastasis, 2015, 32(6):623-635.
[16]
Kee JY, Ito A, Hojo S, et al. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model [J]. Oncology Reports, 2013, 29(3):975-982.
[17]
王杉, 申占龙. 对我国结直肠癌肝转移治疗现状的思考 [J]. 中华胃肠外科杂志, 2012, 15(10):993-996.
[18]
Enquist IB, Good Z, Jubb AM, et al. Lymph node-independent liver metastasis in a model of metastatic colorectal cancer [J]. Nature Communications, 2014, 5(5):3530.
[19]
Zhang Y, Davis C, Ryan J, et al. Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver [J]. Clinical & Experimental Metastasis, 2013, 30(7):903-904.
[20]
Lee HS, Kim HO, Hong YS, et al. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery [J]. Journal of Nuclear Medicine, 2014, 55(4):582-529.
[21]
Ye LC, Ren L, Qiu JJ, et al. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis [J]. Tumor Biology, 2015, 36(11):1-8.
[22]
马宽生, 王青兵. 结直肠癌肝转移射频治疗的现状与进展 [J]. 中华消化外科杂志, 2016, 15(2):117-122.
[23]
Lee H, Choi DW, Cho YB, et al. Recurrence pattern depends on the location of colon cancer in the patients with synchronous colorectal liver metastasis [J]. Annals of Surgical Oncology, 2014, 21(5):1641-1646.
[24]
王青兵, 蒋家云, 谭运华, 等. 结直肠癌肝转移治疗10年随访:单中心120例分析 [J]. 中华肝胆外科杂志, 2015, 21(7):449-453.
[25]
赵明, 王健鹏, 吴沛宏. 射频消融治疗结直肠癌肝转移的现状 [J]. 中华肿瘤杂志, 2011, 33(6):401-404.
[26]
Maruyama T, Murata S, Nakayama K, et al. Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer [J]. Oncology Reports, 2013, 31(2):625-633.
[27]
Lin Q, Tan HT, Lim TK, et al. iTRAQ analysis of colorectal cancer cell lines suggests Drebrin (DBN1) is overexpressed during liver metastasis [J]. Proteomics, 2014, 14(11):1434-1443.
[28]
Chen H, Peng H, Liu W, et al. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis [J]. Surgery, 2015, 158(6):1704-1173.
[29]
孙志强, 陈健, 黄志成, 等. 介入热化疗栓塞联合125I粒子植入治疗大肠癌肝转移的临床观察 [J]. 中华放射医学与防护杂志, 2016, 36(4):294-297.
[30]
Nakayama N, Yamashita K, Tanaka T, et al. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis [J]. Clinical & Experimental Metastasis, 2016, 33(1):3-13.
[1] 涂鹏, 张晓航, 董虹美, 陈功立, 冉素真. 超声多普勒评估在双胎输血综合征射频消融减胎术后的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(05): 492-497.
[2] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[3] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[4] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[5] 付佳, 肖海敏, 武曦, 冯涛, 师帅. 年龄校正查尔森合并症指数对腹腔镜结直肠癌围手术期并发症的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 336-341.
[6] 薛永婷, 高峰, 王雅楠, 屈莲平. 溶瘤病毒治疗在结直肠癌中的应用[J]. 中华普通外科学文献(电子版), 2023, 17(05): 380-384.
[7] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[8] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[9] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[10] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[11] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[12] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[13] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[14] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[15] 孙昕, 程海波, 沈卫星. 基于全转录组学探讨仙连解毒方治疗Ⅲ期结直肠癌患者的疗效机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 277-283.
阅读次数
全文


摘要